Navigation Links
WuXi PharmaTech Congratulates the 2010 Nobel Laureates in Chemistry
Date:10/10/2010

SHANGHAI, Oct. 10 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today extended its congratulations to Dr. Richard Heck, Dr. Ei-ichi Negishi, and Dr. Akira Suzuki on winning the 2010 Nobel Prize in Chemistry. The prize was awarded for the development of palladium-catalyzed cross coupling, which has vastly improved the ability of chemists to create sophisticated chemical compounds. Dr. Negishi spoke at WuXi headquarters in July in the company's Science Seminar Series.

Dr. Negishi graduated from the University of Tokyo in 1958 and did his internship at Teijin Ltd., a Japanese pharmaceutical and chemical company. He earned a Ph.D. from the University of Pennsylvania in 1963 under the supervision of Dr. Allan Day. In 1966, he became a postdoctoral researcher at Purdue University, and he served as assistant to Nobel laureate Dr. Herbert Brow beginning in 1968. He was appointed assistant professor of chemistry at Syracuse University in 1972 and full professor at Purdue University in 1979. Dr. Negishi is the author or co-author of more than 375 papers, 30 essays, and two books.

WuXi scientists were highly impressed by Dr. Negishi's lectures in July, titled "Evolution of the Pd-Catalyzed Cross-Coupling for C-C Bond Formation: Complementary with the Grignard Chemistry" and "Zirconium-Catalyzed Asymmetric Carboalumination of Alkenes." The WuXi PharmaTech Science Seminar Series is a monthly program that invites the world's top scientific minds and leaders in the pharmaceutical industry to speak to the company's scientists. The program aims to keep them informed about the latest developments in a broad range of topics in pharmaceutical research and development.

"Congratulations to Dr. Negishi, Dr. Heck, and Dr. Suzuki on winning the 2010 Nobel Prize in Chemistry," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi AppTec. "I would again like to extend my sincere appreciation to Dr. Negishi for sharing his expertise and knowledge with WuXi PharmaTech's scientists. We have gained inspiration and insight from these world-class scientists." For more information, please contact:Stephanie Liu (for the media)Tel:   +86-21-5046-4362Email: Stephanie_liu@wuxiapptec.comRonald Aldridge (for investors)Tel:   +1-201-585-2048Email: Ron_Aldridge@wuxiapptec.com
'/>"/>

SOURCE WuXi PharmaTech
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
2. WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
3. Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition
4. WuXi PharmaTech Appoints Jeff Leng to Its Board of Directors
5. WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance
6. WuXi PharmaTech Schedules Third Quarter 2008 Earnings Release on Wednesday, November 12, 2008
7. WuXi PharmaTech Signs New Collaboration Agreement With Pfizer
8. WuXi PharmaTech Announces Third Quarter 2008 Results
9. WuXi PharmaTech Appoints Ying Han to Its Board of Directors
10. WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services
11. Pharmatech 2.0: Introducing Pharmatech Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 26, 2017 , ... Cambridge Semantics , the ... Anzo Smart Data Lake® (Anzo SDL) product won ‘Best Text Analytics and ... Awards. , Cambridge Semantics’ Anzo SDL uses Knowledge Graphs based on semantic ...
(Date:7/26/2017)... ... July 25, 2017 , ... In this webinar ... of the considerations needed for designing ideal guide RNAs and DNA oligo or ... create targeted double-strand breaks in genomic DNA has greatly simplified strategies for precise ...
(Date:7/26/2017)... ... July 26, 2017 , ... DuPont Pioneer (DuPont) ... crop productivity and economics for the food, feed and biofuel industries, announced today ... includes the research and development of microbiome-based seed treatments in corn. The goal ...
(Date:7/24/2017)... ... ... Charm Sciences, Inc. is pleased to announce the Charm® ROSA® Tetracycline-SL (Dilution ... (NCIMS) Laboratory Committee and Appendix N Committee as a drug residue test kit for ... voted at its annual meeting in April, 2015 to establish a pilot program to ...
Breaking Biology Technology:
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at ... between startups and global businesses, taking place in ... startups will showcase the solutions they have built with IBM ... France is one of the most ... increase in the number of startups created between 2012 and ...
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
(Date:4/13/2017)... , April 13, 2017 According to a new ... Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, ... IAM Market is expected to grow from USD 14.30 Billion in 2017 ... (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):